[New prospects in the treatment of arterial hypertension. Antagonist of angiotensin II valsartan (diovan)].
Ivleva
A Ia
AIa
D000804:Angiotensin II / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000959:Antihypertensive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D012449:Safety; D013777:Tetrazoles / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016896:Treatment Outcome; D014633:Valine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000068756:Valsartan
D000959:Antihypertensive Agents; D013777:Tetrazoles; D000804:Angiotensin II; D000068756:Valsartan; D014633:Valine
Novye perspektivy v lechenii arterial'noĭ gipertonii. Antagonist angiotenzina II valsartan (diovan).